These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 27526027)

  • 1. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
    Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
    PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
    Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
    Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
    Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation.
    Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
    Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
    Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
    Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
    Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke and muscle catabolism in C2 myotubes.
    Rom O; Kaisari S; Aizenbud D; Reznick AZ
    Mech Ageing Dev; 2013; 134(1-2):24-34. PubMed ID: 23262287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients.
    Pomiès P; Rodriguez J; Blaquière M; Sedraoui S; Gouzi F; Carnac G; Laoudj-Chenivesse D; Mercier J; Préfaut C; Hayot M
    J Cell Mol Med; 2015 Jan; 19(1):175-86. PubMed ID: 25339614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
    Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
    J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress regulates autophagy in cultured muscle cells of patients with chronic obstructive pulmonary disease.
    Gouzi F; Blaquière M; Catteau M; Bughin F; Maury J; Passerieux E; Ayoub B; Mercier J; Hayot M; Pomiès P
    J Cell Physiol; 2018 Dec; 233(12):9629-9639. PubMed ID: 29943813
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lee MK; Choi YH; Nam TJ
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway.
    Wang Y; Chu Y; Dai H; Zheng Y; Chen R; Zhou C; Zhong Y; Zhan C; Luo J
    Int Immunopharmacol; 2024 May; 133():112133. PubMed ID: 38652962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
    Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
    PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
    Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
    J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.